Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

Fine-Tuning Stem Cell Therapy to Repair the Heart

By BiotechDaily International staff writers
Posted on 27 Mar 2013
Stem cells have the potential to grow into a range of cell types, including heart cells. Researchers are now trying to refine the process of repairing and regenerating heart tissue damaged by a heart attack with stem cells.

A recent study from Cedars-Sinai Heart Institute (Los Angeles, CA, USA) suggests that stem cells may, undeniably, heal damaged hearts. The researchers treated 17 heart attack survivors with an infusion of stem cells taken from their own hearts. One year later, the amount of scar tissue had shrunk by about 50%. These findings look dramatic, but investigators are wondering if they an indication that they are close to perfecting stem cell therapy.

“This is a field where, depending on which investigator you ask, you can get incredibly different answers,” Dr. Richard Lee, professor of medicine at Harvard Medical School (Boston, MA, USA), and a leading specialist on stem cell therapy, reported in the March 2013 issue of Harvard Women’s Health Watch. “The field is young. Some studies show only modest or no improvement in heart function, but others have shown dramatically improved function. We’re waiting to see if other doctors can also achieve really good results in other patients.”

New research is generating contrary findings in part, because researchers use diverse approaches to harvest and use stem cells. Some are gathered from the bone marrow of donors, others from the recipient’s own heart. It is not evident which approach works optimally. “Some investigators think this is just a few years away,” concluded Dr. Lee. “And then there are others who feel that there is much more work to be done.”

Presently, stem cell therapy is available only to individuals who participate in a research trial.

Related Links:

Cedars-Sinai Heart Institute
Harvard Medical School




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.